Prevenar13

ApprovedBiologic

GSK

Prevenar13 is one of 96 biologic programs targeting Liver Transplant. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Liver TransplantActive, not recruiting

HepatitisActive, not recruiting

Splenectomised PatientsCompleted

Herpes ZosterActive, not recruiting

Liver TransplantApproved

Active, not recruiting

HepatitisApproved

Active, not recruiting

Splenectomised PatientsPhase 2

Completed

Herpes ZosterPhase 3

Active, not recruiting

Competition

Competitive Landscape

353 competitors in Liver Transplant

#DrugCompanyPhaseTrials

Prevenar13

GSK

Approved

1 2

Cysteine Hydrochloride

Novartis

Preclinical

3 3

Octreotide

Johnson & Johnson

Preclinical

2 4

Lenvima

Eisai

Preclinical

2 5

Beyfortus

BeiGene

Preclinical

1 6

Prostigmin

Merck & Co.

Preclinical

1 7

Precedex

MMcNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.

Preclinical

4 8

Myfortic

Novartis

Preclinical

6 9

Cyklokapron

AAmring

Preclinical

2 10

Neo-Synephrine

EExela Pharma Sciences, LLC.

Preclinical

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Immunogenicity3 trials

Immunogenicity and Safety of 13-valent Pneumococcal Conjugate Vaccine Among HIV-infected Adults

Completed·KKorea University Guro Hospital·Phase 4·NCT03838497·70 enrolled

Safety and Immunogenicity of the 'EuPCV15' in Healthy Korean Adults

Completed·EEuBiologics Co.,Ltd·Phase 1·NCT04830358·60 enrolled

Immunogenicity and Safety of PCV13 and Fluad in Adults Aged ≥60 Years

Completed·KKorea University Guro Hospital·Phase 4·NCT02215863·1,195 enrolled

Vaccination2 trials

PNEUMOCELL - Conjugated Pneumococcal Vaccination in Patients With Immunoglobulin G-deficiency

Completed·KKarolinska University Hospital·Phase 2·NCT01847781·20 enrolled

Assessment of Novel Pneumococcal Conjugate Vaccination Scheduled in UK Infants

Withdrawn·PPublic Health England·Phase 4·NCT02918708

Pneumococcal Vaccines2 trials

Using Pneumococcal Vaccines in Combination for Maximum Protection From Ear and Lung Infections in First 3 Years of Life

Completed·MMenzies School of Health Research·Phase 4·NCT01735084·261 enrolled

Pneumococcal Vaccines Early and in Combination

Completed·MMenzies School of Health Research·Phase 4·NCT01174849·425 enrolled

Liver Transplant1 trial

Immunogenicity of 13-valent Pneumococcal Conjugate Vaccine Compared to the Pneumococcal Polysaccharide Vaccine in Adult Kidney and Liver Transplant Patients

Completed·HHelsinki University Central Hospital·Phase 4·NCT01781871·182 enrolled

Hepatitis1 trial

PCV13 + Hepatitis a Vaccine for Adults

Completed·HHelsinki University Central Hospital·Phase 4·NCT01926860·305 enrolled

3 more indications

Herpes Zoster1 trial

Immunogenicity and Safety Study of GSK Biologicals' Herpes Zoster Vaccine GSK1437173A When Co-administered With Prevenar13 in Adults Aged 50 Years and Older

Completed· GSK logo

GSK·Phase 3·NCT03439657·913 enrolled

Clinical Trial1 trial

Clinical Trial of PCV24 in Children Aged 2-17 Years

Completed·SSinovac Life Sciences Co., Ltd.·Phase 1·NCT06550830·119 enrolled

Splenectomised Patients1 trial

Evaluation of Immunological Response Following a Revaccination With PPS23 Boosted or Not by PCV13 in Splenectomised Patients

Completed·AAssistance Publique - Hôpitaux de Paris·Phase 2·NCT03873727·39 enrolled

Sources

References

[1]
ClinicalTrials.gov — 12 trial records for Prevenar13. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Prevenar13 compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Prevenar13. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — GSK company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Biologic[2]
Highest Phase: Approved[1]
Company: GSK

Prevenar13

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Immunogenicity3 trials

Vaccination2 trials

Pneumococcal Vaccines2 trials

Liver Transplant1 trial

Hepatitis1 trial

Herpes Zoster1 trial

Clinical Trial1 trial

Splenectomised Patients1 trial

References

Drug Info

Quick Facts

Related News